Patients affected by vitiligo and autoimmune diseases do not show antibodies interfering with the activity of the melanocortin 1 receptor.
Agretti
P
P
Department of Endocrinology and Metabolism, Centro Eccellenza AmbiSEN, University of Pisa, Via Paradisa 2, Pisa, Italy.
De Marco
G
G
Sansone
D
D
Betterle
C
C
Coco
G
G
Dimida
A
A
Ferrarini
E
E
Pinchera
A
A
Vitti
P
P
Tonacchera
M
M